Andon Research Development from 2010 to 2024

002432 Stock   43.60  0.34  0.79%   
Andon Health's Research Development is increasing over the years with slightly volatile fluctuation. Overall, Research Development is expected to go to about 292.4 M this year. From 2010 to 2024 Andon Health Research Development quarterly data regression line had arithmetic mean of  96,129,548 and r-squared of  0.68. View All Fundamentals
 
Research Development  
First Reported
2018-06-30
Previous Quarter
53.9 M
Current Value
65.2 M
Quarterly Volatility
24.4 M
 
Covid
Check Andon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Andon Health's main balance sheet or income statement drivers, such as Interest Expense of 13.1 M, Selling General Administrative of 353.9 M or Total Revenue of 3 B, as well as many indicators such as . Andon financial statements analysis is a perfect complement when working with Andon Health Valuation or Volatility modules.
  
This module can also supplement various Andon Health Technical models . Check out the analysis of Andon Health Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Andon Stock

Andon Health financial ratios help investors to determine whether Andon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Andon with respect to the benefits of owning Andon Health security.